DocSym
β
Searchsearch
Search
(L30.2) Cutaneous autosensitization
More details coming soon
1 425 183 in individuals diagnosis cutaneous autosensitization confirmed
2 954 deaths with diagnosis cutaneous autosensitization
Diagnosis cutaneous autosensitization is diagnosed Men are 1.42% more likely than Women
722 739
Men receive the diagnosis cutaneous autosensitization
1 922 (0.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
702 444
Women receive the diagnosis cutaneous autosensitization
1 032 (0.1 %)Died from this diagnosis.
Risk Group for the Disease cutaneous autosensitization - Men aged 55-59 and Women aged 80-84
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features cutaneous autosensitization
Absence or low individual and public risk
Cutaneous autosensitization - what does this mean
Cutaneous autosensitization is a rare, idiopathic disorder in which the skin develops an allergic reaction to its own proteins. it is caused by an abnormal immune response to the skin's own proteins, resulting in the formation of antibodies that then cause inflammation and itching on the skin.
What happens during the disease - cutaneous autosensitization
Cutaneous autosensitization is a rare skin disorder that is caused by repeated contact with a triggering agent, such as a chemical or other irritant. this repeated exposure leads to sensitization of the skin, where it becomes more susceptible to further irritation. as a result, the skin reacts to even small amounts of the triggering agent, and can cause inflammation, itching, and burning. in some cases, it can also lead to the formation of blisters or ulcers.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of the affected area
- Skin biopsy
- Blood tests to identify allergic antibodies
- Patch testing
- Allergy skin prick tests
- Skin prick tests with suspected allergens
- Intradermal tests with suspected allergens
Treatment and Medical Assistance
Main goal of the treatment: Reduce the symptoms and severity of Cutaneous Autosensitization.
- Avoidance of allergens
- Topical corticosteroids
- Antihistamines
- Phototherapy
- Systemic immunosuppressants
- Allergen-specific immunotherapy
- Oral corticosteroids
- Topical calcineurin inhibitors
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Cutaneous autosensitization - Prevention
Cutaneous autosensitization can be prevented by avoiding contact with potential allergens, such as certain foods, medications, and chemicals. it is also important to practice good hygiene, as this can help reduce the risk of skin irritation and infection. additionally, it is important to wear protective clothing when handling known allergens.